Cameroon currently reports a pharmaceuticals, medicinal chemicals, seasonally adjusted index of 82.9, a decrease of 0.3 (-0.4%) from 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in Cameroon
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to Cameroon
Pharmaceuticals, medicinal chemicals
Cameroon Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals, medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 82.9 | -0.3 |
| 2023 Q4 | 83.2 | +3.8 |
| 2023 Q3 | 79.4 | -5.3 |
| 2023 Q2 | 84.7 | +21.2 |
| 2023 Q1 | 63.5 | -49.8 |
| 2022 Q4 | 113.3 | +26.5 |
| 2022 Q3 | 86.8 | +5.8 |
| 2022 Q2 | 81.0 | +23.1 |
| 2022 Q1 | 57.9 | -12.9 |
| 2021 Q4 | 70.8 | +7.2 |
| 2021 Q3 | 63.6 | -34.1 |
| 2021 Q2 | 97.7 | -5.3 |
| 2021 Q1 | 103.0 | +29.0 |
| 2020 Q4 | 74.0 | -3.3 |
| 2020 Q3 | 77.3 | -0.7 |
| 2020 Q2 | 78.0 | -20.2 |
| 2020 Q1 | 98.2 | +11.5 |
| 2019 Q4 | 86.7 | +8.1 |
| 2019 Q3 | 78.6 | -1.5 |
| 2019 Q2 | 80.1 | -19.4 |
| 2019 Q1 | 99.5 | +10.5 |
| 2018 Q4 | 89.0 | +28.9 |
| 2018 Q3 | 60.1 | +1.2 |
| 2018 Q2 | 58.9 | -33.0 |
| 2018 Q1 | 91.9 | -1.7 |
| 2017 Q4 | 93.6 | -16.2 |
| 2017 Q3 | 109.8 | -3.6 |
| 2017 Q2 | 113.4 | -5.9 |
| 2017 Q1 | 119.3 | +20.8 |
| 2016 Q4 | 98.5 | +18.3 |
| 2016 Q3 | 80.2 | -12.3 |
| 2016 Q2 | 92.5 | -5.9 |
| 2016 Q1 | 98.4 | -1.5 |
| 2015 Q4 | 99.9 | +0.7 |
| 2015 Q3 | 99.2 | +0.7 |
| 2015 Q2 | 98.5 | -3.9 |
| 2015 Q1 | 102.4 | -13.2 |
| 2014 Q4 | 115.6 | +22.6 |
| 2014 Q3 | 93.0 | -2.0 |
| 2014 Q2 | 95.0 | -1.3 |
| 2014 Q1 | 96.3 | -0.8 |
| 2013 Q4 | 97.1 | +0.5 |
| 2013 Q3 | 96.6 | 0.0 |
| 2013 Q2 | 96.6 | +2.7 |
| 2013 Q1 | 93.9 | +72.4 |
| 2012 Q4 | 21.5 | -41.6 |
| 2012 Q3 | 63.1 | +2.9 |
| 2012 Q2 | 60.2 | +7.4 |
| 2012 Q1 | 52.8 | -0.1 |
| 2011 Q4 | 52.9 | -8.1 |
| 2011 Q3 | 61.0 | -1.2 |
| 2011 Q2 | 62.2 | -4.1 |
| 2011 Q1 | 66.3 | +9.9 |
| 2010 Q4 | 56.4 | -2.0 |
| 2010 Q3 | 58.4 | -9.3 |
| 2010 Q2 | 67.7 | -0.5 |
| 2010 Q1 | 68.2 | -2.5 |
| 2009 Q4 | 70.7 | -11.6 |
| 2009 Q3 | 82.3 | -6.9 |
| 2009 Q2 | 89.2 | +0.4 |
| 2009 Q1 | 88.8 | -12.9 |
| 2008 Q4 | 101.7 | +7.0 |
| 2008 Q3 | 94.7 | +1.8 |
| 2008 Q2 | 92.9 | -4.5 |
| 2008 Q1 | 97.4 | -32.7 |
| 2007 Q4 | 130.1 | +2.4 |
| 2007 Q3 | 127.7 | +8.4 |
| 2007 Q2 | 119.3 | +25.1 |
| 2007 Q1 | 94.2 | +7.3 |
| 2006 Q4 | 86.9 | +0.5 |
| 2006 Q3 | 86.4 | -17.5 |
| 2006 Q2 | 103.9 | -10.4 |
| 2006 Q1 | 114.3 | +31.4 |
| 2005 Q4 | 82.9 | -0.8 |
| 2005 Q3 | 83.7 | -15.7 |
| 2005 Q2 | 99.4 | +7.6 |
| 2005 Q1 | 91.8 |